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ABBREVIATIONS 
2D  : 2 dimension 
AS  : Aortic Stenosis 
AVA  : Aortic Valve Area 
BMI  : Body Mass Index 
BSA  : Body Surface Area 
CMR  : Cardiac Magnetic Resonance 
CSA  : Cross Sectional Area 
CT  : Computed Tomography 
CV  : Cardiovascular 
EF  : Ejection Fraction  
ELCo  : Energy Loss Coefficient 
EOA  : Effective Orifice Area 
LV  : Left Ventricle 
LVEF : Left Ventricular Ejection Fraction  
LVOT : Left Ventricular Outflow Tract 
MAPSE : Mitral Annular Plane Systolic Excursion 
VPC  : Ventricular Premature Complex 
VTI  : Velocity Time Integral 
Zva  : Valvuloarterial Impedance 
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INTRODUCTION 
  Aortic Stenosis is one of the major causes of cardiovascular 
morbidity and mortality in the elderly.   It is the most common causes 
for valve surgery in the developed countries (1). 
In recent times aortic stenosis is believed to be due to 
atherosclerotic process affecting the valves along with the great arteries 
(2)
 hence aortic valve disease is also considered to be an abnormality of 
the valve and arterial system together. 
In India, the incidence of isolated aortic valve disease has been 
increasing and many cases of isolated aortic valve disease is being 
diagnosed due to better utilization of healthcare facilities by people and 
due to the decline in the incidence of rheumatic heart disease.  
Newer therapies have been evolving in the treatment of aortic 
valve disease like transcatheter replacement of the aortic valve. In this 
scenario the evaluation of aortic valve pathology has to be precise and it 
should be helpful in guiding treatment. Traditionally the estimation of 
severity of aortic valve stenosis has been based on Echocardiographic 
and Doppler evaluation and these have provided adequate details in 
most of the cases of aortic stenosis. But in patients with coexisting 
hypertension and stiffness of the arterial system the conventional 
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methods of estimation of the severity of aortic stenosis may 
underestimate the magnitude of the severity thereby the ultimate 
treatment may be delayed, moreover a significant number of patients in 
whom AS is severe as defined by the valve area criteria show low 
gradients despite the presence of a good LV function (Paradoxical Low 
flow low gradient AS(3)) since there is a discrepancy between these 
values this might lead to postponement of surgical therapy. But in reality 
these are the subset of patients who are in a more advanced state of 
disease progression, they have concentric remodeling and a smaller LV 
cavity a reduced Stroke volume and increased LV after load, the low 
stroke volume tends to lower the transvalvular gradients. In these 
conditions the estimation of the severity of aortic valve stenosis can be 
done by using other methods. The combination load imposed on the left 
ventricle both by the valve and the arteries in patients with aortic valve 
stenosis can be calculated by a non invasive method using echo-Doppler 
and this is known as the valvuloarterial impedance. In many studies it 
has been shown that high global LV load as quantitated by the increased 
values of valvuloarterial impedance was associated with poor prognosis 
and high valvuloarterial impedance patients had more incidence of 
symptoms , more incidence of cardiovascular mortality and quicker need 
for aortic valve replacement. (3,4,5,6)   So far there has been no medical 
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therapy proven to halt the progression of Aortic Stenosis so surgery 
becomes the mainstay of treatment, thus the proper evaluation of Aortic 
Valve stenosis becomes mandatory before subjecting the patient to a 
procedure that carries a mortality risk of about 2 percent. 
In the natural history of Aortic stenosis the patients after 
development of narrowing of the aortic orifice have a long latent period 
before the development of symptoms of aortic stenosis like angina, 
dyspnoea or syncope, but after the development of these symptoms they 
have a steep downhill course. Severe Aortic stenosis patients who are 
symptomatic are candidates for surgery and without Aortic valve 
replacement only 50% survive up to 2 years and 20% survive up to 5 
years respectively (8). But there are subsets of patients who have severe 
Aortic Stenosis but are asymptomatic, in these patients according to 
current management guidelines they are subjected to exercise stress 
testing and if they develop symptoms they are advised surgery, others 
are advised careful follow up for symptoms or signs of rapid progression 
of disease. In a study done in 544 patients with asymptomatic Aortic 
stenosis it has been shown that high valvuloarterial impedance values 
predicted increase in 4 year mortality and major cardiovascular adverse 
events independent of traditional indices of severity(6).  
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In this scenario we thought that it would be prudent to have a 
study on the valvuloarterial impedance in our south Indian population so 
as to get information regarding the pattern of global LV load in our 
subset of patients with Aortic stenosis and to study the relationship of 
valvuloarterial impedance to patients symptoms and indices of LV 
function and geometry. Since asymptomatic patients with severe aortic 
stenosis and high LV global load had a poor prognosis estimation of 
valvuloarterial impedance in this population would help in risk 
stratification and direct them towards early surgery thereby reducing 
adverse event rate. 
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AIMS AND OBJECTIVES 
 
1.  To study the valvuloarterial impedance levels in south Indian 
population presenting with isolated Aortic valve disease. 
2.  To study the correlation of symptoms of Aortic stenosis with 
levels of valvuloarterial impedance 
3.  To evaluate the relationship between Age, Sex, Body mass index 
and Hypertension and valvuloarterial impedance in patients with 
Aortic stenosis. 
4.  To study the correlation of indices of Left Ventricular geometry 
and Left Ventricular function (systolic, diastolic and global) with 
levels of valvuloarterial impedance  
5.  To evaluate the relationship between mitral annular plane systolic 
excursion and levels of valvuloarterial impedance in aortic 
stenosis patients with normal Ejection fraction, and to unmask 
early Left Ventricular longitudinal dysfunction. 
6.  To compare the indices of Aortic stenosis severity to levels of 
valvuloarterial impedance. 
7.  To evaluate the Doppler echocardiographic characteristics of 
patients with asymptomatic Aortic stenosis. 
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REVIEW OF LITERATURE 
The earliest descriptions about Aortic stenosis was done by 
Lazare Riviere, a French physician as early as 1663 AD as autopsy 
findings in a patient with breathlessness, palpitations and absent pulses 
in the extremities. In modern day medicine the description of calcific 
aortic valve disease were first given by Moenckeberg in 1904(9). 
Aortic stenosis is the commonest valve disease in the developed 
nations. In patients with asymptomatic aortic stenosis the mortality rate 
without intervention is 50 % within 4 years of symptom onset (10). Aortic 
valve disease is not a simple degenerative process but is a complex 
disease where congenital, genetic, environmental & molecular 
mechanisms play a role (2, 11). 
Aortic valve anatomy 
The aortic valve is the major valve in the heart operating at high 
pressure and it is usually tricuspid. The incidence of Bicuspid aortic 
valve is 1-2% in the general population still lesser numbers of patients 
have unicuspid aortic valves. 
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In normal persons the aortic valve opens and shuts about 100,000 
times a day and allows 2-20 liters of blood to pass through it per minute 
depending upon the levels of physical activity (12). 
An important function of the aortic valve is to provide 
streamlined laminar flow from the LV into the aorta and to prevent the 
backflow of blood into the ventricles during diastole. The effect of aortic 
valve also helps the LV in maintaining its normal function. The aortic 
sinuses above the aortic valve is the site where the coronaries originate, 
since the coronary flow occurs predominantly during diastole the aortic 
valve the aortic valve mechanism provides a system by which pressure 
currents are created in the aortic sinuses aiding diastolic coronary flow. 
(13, 15)
 In aortic valve disease the processes are in jeopardy leading to 
deleterious effects on coronary perfusion and Left Ventricular function. 
Epidemiology  
Aortic valve stenosis is predominantly a disease of the elderly 
population and it is the most frequent causes of valve disease and valve 
replacement in the developed world. (1) Aortic valve sclerosis is a 
condition in which there is thickening of the aortic valve leaflets without 
significant obstruction to the outflow of increase in gradient across the 
aortic valve. With progressive increase in age there is a progressive 
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increase in incidence of Aortic Sclerosis and Aortic stenosis. 
Throughout the world, studies done have shown that of the valvular 
heart diseases, aortic valve disease is the commonest and it constitutes 
43% of cases of valvular heart disease. Aortic valve sclerosis is now 
thought to be a forerunner of aortic stenosis and the pathology is the 
same for both the conditions. In studies it has been shown that in elderly 
individuals of age >65 years the incidence of aortic sclerosis was about 
29% and the incidence of Aortic stenosis varied from 2-9%.Of the 
persons with aortic valve sclerosis 1.7% patients progress to aortic 
stenosis in a year. Aortic valve sclerosis as thought previously is not a 
benign entity but is associated with a 50% increased risk of coronary 
artery disease compared to the general population. (15) Aortic valve 
disease occurs more commonly in males. 
In the Helsinki Ageing study(1) done in elderly patients about 53% 
had calcification of the aortic valves of these 40% had mild calcification 
and 13% had severe calcification, in this study 5% of the participants 
had moderate degrees of Aortic stenosis and 2.9% had severe aortic 
stenosis. 
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In another study done in African Americans 18.6% of the 
participants between the age of 65 to 75 years were found to have aortic 
valve sclerosis.(16) Of the factors affecting the aortic valve, Rheumatic 
heart disease affects the aortic valve in about 40-45% and it usually 
coexists with mitral valve disease. The aortic cusps in RHD are 
thickened calcified and have a fused commisure. In developed nations 
the incidence of Rheumatic AS is very less. Other conditions that might 
lead to aortic valve stenosis are Paget’s disease, Familial 
Hypercholesterolemia, Chronic kidney disease and chest radiotherapy. 
Congenital AS is an uncommon cause of Aortic stenosis and the 
aortic valve may be bicuspid unicuspid or tricuspid. usually congenital 
bicuspid aortic valve is not associated with stenosis at birth but 
gradually develops stenosis by early adulthood. 
Degenerative calcific aortic stenosis is the commonest cause for 
aortic stenosis in adults and it is the commonest cause for aortic valve 
replacement in adults. (2) 
Usually the risk factors for developing AS are similar to those of 
atherosclerotic vascular disease like smoking, high blood pressure male 
sex, increasing age, high LDL cholesterol levels, and increased BMI. (17) 
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It  is  also noted that presentation of bicuspid aortic valve is 2 decades 
earlier than (40-60 years) tricuspid aortic valve stenosis  
(60 -70 years). (18)  
In a study done by Olsen et al in 2005(19) in 960 hypertensive 
patients the prevalence of Aortic valve sclerosis was found to be 40.4% 
and 1.6% of the study population had Significant aortic valve disease, 
the patients with Aortic valve sclerosis had thicker ventricles , more LV 
mass and LV mass indexed to body surface area. This study also showed 
that Aortic valve stenosis and sclerosis was a significant risk factor for 
CV mortality, Myocardial infarction and stroke. 
Pathophysiology 
In aortic valve stenosis the obstruction to the ventricular outflow 
causes left ventricular concentric hypertrophy and increase in thickness 
of LV and the mass of the LV is also increased, this  is a compensatory 
mechanism and it decreases the Left ventricular wall  tension. In a 
majority of persons with aortic valve stenosis the size of the LV cavity 
is usually within the normal limits and the Left ventricular systolic 
function is also normal, in later stages when the compensatory 
mechanisms fail there is a progressive dilatation of the left ventricle and 
decrease in LV function. 
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 The altered physiology in aortic valve stenosis is due to three 
main factors – first is the increase in the load against which the LV has 
to pump – the after load, second is the decrease in blood supply to the 
LV myocardium due to decreased coronary flow and increase in LV 
thickness, and third is the hypertrophy of the left ventricle leading to 
diastolic and systolic left ventricular dysfunction.  
 The three classic symptoms of aortic valve stenosis i.e. dyspnoea, 
angina, and syncope are brought about by the above mechanisms. 
Patients with AS and normal LV function also have effort induced 
breathlessness. Diastolic left ventricular function abnormalities are 
usually the norm in significant aortic valve stenosis and the elevated left 
ventricular filling pressures are eventually transmitted to the pulmonary 
circulation leading on to dyspnoea .the reasons for diastolic dysfunction 
is multiple and it is due to the stiff non compliant ventricle, decreased 
myocardial blood supply and due to an increase in LV afterload.  
Ischemia develops as the coronary blood supply cannot match the 
needs of the hypertrophied myocardium and hypoxemia of the 
myocardium ensues the elevated diastolic pressures within the LV 
cavity also hamper the blood supply worsening the angina. Symptoms of 
exertional angina may be present in the absence of epicardial coronary 
artery obstruction.  
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Syncope in Aortic stenosis has varied causes, the reasons for 
syncope may be due to the onset of Arrhythmias ( Brady or Tachy 
arrhythmias), due to the obstruction to the outflow leading to coronary 
and cerebral insufficiency or due to activation of various autonomic 
vasodepressor reflexes triggered by the stress induced activation of the 
mechanoreceptors in the left ventricle. 
 When the left ventricle is subjected to chronic pressure overload 
the afterload mismatch phenomenon results in deterioration of the Left 
ventricular function and this in turn in due course of time also results in 
right heart failure .The onset of right heart failure results in systemic 
hypotension further decreasing the coronary perfusion and worsening 
ischemia leading to an irreversible downward spiral. 
As a progressive, long-standing pressure overload is placed on the 
left ventricle, systolic decompensation may occur from the afterload 
mismatch and lead to symptoms of both left-sided and right-sided heart 
failure. (20, 21) 
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Echocardiographic evaluation of Aortic stenosis (22) 
Doppler and 2 dimensional Echocardiography are the 
investigations of choice for the diagnosis and to estimate the severity of 
Aortic stenosis. Echocardiography is useful in studying the anatomy of 
the valve, gives information about the left ventricular function and 
evaluates the hydraulic behavior of the aortic valve. 
   
 
 
 
 
 
 
 
Identification of AS etiology by Echo 
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The above are the recommended measurements to be obtained in 
patients with aortic stenosis while performing Echocardiography. 
Echo criteria for the severity of AS (22)    (ACC/AHA guideline 
values marked *) 
 
Aortic 
Sclerosis Mild AS Moderate AS Severe AS 
Aortic jet velocity 
(m/s) <2.6 2.6–3.0 3–4 >4 
Mean gradient 
(mmHg) — <30 (25*) 
30–50 (25–
40*) >50 (40*) 
AVA (cm2) — >1.5 1.0–1.5 <1.0 
Indexed AVA 
(cm2/m2)  >0.9 0.6–0.9 <0.6 
Velocity ratio 
 
>0.50 0.25–0.50 <0.25 
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Measurements for AS severity to be obtained by Doppler Echo 
 
 
 
 
 
 
 
 
 
 
 
  
 1 to 3 Essential in all patients with Aortic stenosis (yellow);  
 4 to 6 Reasonable where additional information is required in selected 
groups (green); and 7 to 11 routinely not recommended (blue). 
 
 
23 
Imaging of the Aortic valve 
2D Imaging  
The 2 dimensional views that are used to evaluate the Aortic 
valve are the parasternal long axis view, the parasternal short axis view 
at the level of the aortic valve and the apical long axis view, in some 
cases the sub- xiphoid short axis view is also useful. These views can 
identify the number of cusps and the degree of calcification. The aortic 
valve area may be calculated by planimetry but is does not correlate 
with the hemodynamically determined effective orifice area. 
Echocardiographic assessment of Left Ventricular function  
Assessment of left ventricular function is a part and parcel of 
Echocardiography in Aortic stenosis the minimum information required 
about the left ventricle is the standard measurement of Left ventricular 
dimensions, the measurements that are usually made are the dimensions 
of the interventricular septum , the posterior wall and the left ventricular 
cavity dimensions the relative wall thickness is calculated. These indices 
help us to identify the alterations in left ventricular geometry. Many 
studies have shown that LV geometry is altered in AS and concentric 
remodeling is common in aortic stenosis and it has also been shown that 
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men with aortic stenosis tend to have dilated LV cavities in later stages 
of disease. (23)  
Next is the assessment of left ventricular ejection fraction and 
fractional shortening. The left ventricular function assessment should 
also include long axis function measure using tissue Doppler or using 
M-mode echocardiography. 
Third part of evaluation of the Left ventricle consists of obtaining 
the time velocity integral of the outflow tract. It is done using pulse 
wave Doppler with sample volume placed in the LVOT. 
The fourth part of assessment of LV consisting of assessing the 
degree of diastolic dysfunction this is done using pulsed wave Doppler 
in the mitral inflow or using tissue Doppler techniques. 
Doppler measurements in aortic stenosis 
The minimum data to be collected are the V max or peak velocity, 
the mean transvalvular gradient and calculation of Effective orifice area 
by the continuity equation.  
In measuring the V max of peak velocity, the continuous wave 
Doppler is aligned parallel to the aortic valve in the apical five chamber 
view so that the spectrum is clear and uniform. The signal with uniform 
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contour and highest peak is chosen for the measurement avoiding the 
artifacts. Usually post VPC beats are avoided and in patients with atrial 
fibrillation the average V max of five beats is taken. Using the V max 
the peak gradient can also be calculated using the Bernoulli equation. 
(∆P = 4 V2, where V is the V max) 
 In the continuous wave signal spectrum the morphology of the 
spectrum helps in identification of the severity of stenosis, a triangular 
signal indicates severe AS but an early peaking in the signal spectrum 
indicates mild AS. (22) 
The mean gradient is a value that is obtained by the integral of all 
the instantaneous gradients over time so the mean gradient reflects 
faithfully the stenosis severity than the peak gradient. 
 The aortic valve area is calculated using the continuity equation  
For calculation of the aortic valve area by using the continuity 
equation the apical three chamber view and the apical five chamber 
view are used. The cursor is aligned properly parallel to the direction of 
flow and continuous wave Doppler flow is recorded across the aortic 
valve and pulse wave Doppler tracings are recorded across the left 
ventricular outflow tract. 
26 
Continuity equation  
 
 
 
 
 
 
Here A1 x VTI 1 = A2 xVTI2 
 
Calculation of Aortic valve area by the continuity equation is the 
method which is widely accepted. The basis of the continuity equation is 
that the stroke volume passing through the LV outflow is equal to the 
stroke volume crossing the stenosed aortic valve: 
       AVA × VTI AS = CSA LVOT × VTI LVOT 
 AVA - aortic valve area, 
 VTIAS and VTILVOT - velocity time integrals in the effective valve orifice 
and LVOT, respectively,         
 CSA LVOT - cross-sectional area of the LVOT  
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This method is prone for error since this assumes that the LVOT is 
circular in shape also requires the measurement of the LVOT size and 
the velocity at exactly the same place. The flow velocity in the LVOT is 
measured in the apical view using pulse Doppler assuming that the flow 
is laminar, so this method is not so accurate. (22, 23) 
Pressure recovery and gradients  
Currently the guidelines for the diagnosis for the diagnosis and 
management of aortic stenosis does not make distinction between 
Doppler based and cath based measurements. But catheterization 
derived gradients measure the net gradient between the LV and Aorta 
but the Doppler estimates the maximal velocity drop through the 
stenotic valve from the maximum velocity recorded. But as the blood 
flow decelerates between the valve and the aorta some amount of the 
kinetic energy is converted back into potential energy in the proximal 
aorta due to a phenomenon known as the pressure recovery. So the 
gradients measured by catheterization are always less than the gradients 
recorded by Doppler echocardiography. Similarly the effective orifice 
areas which are calculated using Gorlin’s  formula in cath is based on 
pressure recovered values and is usually higher than the Effective orifice 
area calculated by Doppler using the continuity equation. 
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The ratio between the Effective orifice area and the proximal 
aorta cross section governs the  extent of pressure recovery ,This 
becomes very important in patients with moderate AS (EOA – 0.8 to1.2 
cm2)and small aortas (ST junction <3.0 cm)where the measurement of 
the gradients might overestimate the severity of Aortic stenosis. 
To overcome this some formulas have been proposed and they include 
the formula proposed by Baumgartner et al (24) and the Energy loss 
coefficient proposed by Garcia et al (25) 
ELCo= (EOA x AA / AA - EOA),  
 AA is the CSA of the aorta measured at 1 cm distal of the 
sinotubular junction 
Another index called stroke work loss gives indirect information 
on pressure recovery and it is calculated as the ratio of the mean 
transvalvular gradient to the estimated LV systolic pressure. 
Some studies have shown that including these parameters may be 
superior to using the gradients or EOA alone to predict adverse 
outcomes. (26)  
 
29 
Body surface area measurements  
For two patients with the same EOA but different Body surface 
areas the load imposed on the ventricle by the stenotic lesion will be 
higher in the patient with a higher body surface area and it will be lower 
in patients with lesser body surface area. So the larger patient has an 
underestimation of severity and a smaller patient has overestimation of 
severity. So to overcome this pitfall indexed values are used 
The concept of vascular load 
Aortic stenosis is a complex disease and it is considered to be a 
disease affecting the valve as well as the aorta and the pathology in 
calcific aortic stenosis is similar to atherosclerosis and medial 
elastocalcinois. Even in young patients with bicuspid aortic valve there 
are coexisting abnormalities of the aortic media which lead to excessive 
stiffness of the aorta and patients may also have aortic dilatation. Elderly 
patients with decreased compliance of the aorta also tend to have 
systolic hypertension  
Briand et al in a study done in 2005 (4) reported that in 
approximately 40% of patients with Aortic stenosis the total systemic 
arterial compliance was reduced (<0.6ml.m-2.mmHg-1). The systemic 
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arterial compliance was calculated by dividing the Stroke Volume index 
by pulse pressure. This reduced compliance causes an increase in the LV 
afterload and this in turn leads to left ventricular dysfunction and 
culminates in increase in adverse events.   
The systemic arterial compliance reflects the pulsatile component 
of the arterial load but there also exists a steady component in the 
arterial tree that is estimated by calculation of the Systemic vascular 
resistance .the systemic vascular resistance is calculated as follows 
SVR = (80 x mean arterial pressure)/CO 
CO is the cardiac output measured in the LVOT by Doppler  
Mean arterial pressure = diastolic pressure + pulse pressure  
In this context it should be noted that normal BP  does not 
exclude an increased vascular load because the BP may be falsely low in 
about 30% of patients with decreased compliance, this may be due to a 
reductio  in cardiac output or due to LV systolic dysfuction.  
Relationship between aortic stenosis severity and hypertension  
Studies have shown that coexisting systemic hypertension was 
present in 35 to 51% of patiens with aortic stenosis .Increase in pulse 
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pressure and elevation of systolic blood pressure are the features of 
reduced compliance . So we should be aware that the the parameters of 
AS severity might be affected the presence of hypertension and the 
amount of alteration caused by hypertension on AS severity is difficult 
to measure. In Catheterisation based measrements decreased arterial 
compliance due to hypertension decreases the peak to peak gradient  and 
it also alters the other indices of AS severity.These changes are brought 
about by the decrease in transvalvular flow, and the severity of stenosis 
is underestimated in patients with hypertension.(28) 
In a study done in animal models (Kadem et al)(27)it was 
demonstrated that the severity of AS may be underestimated in the 
presence of hypertension. So this gives us a valuable point while clinical 
examination and while performing echocardiography that blood pressure 
measurements should be part of the evaluation of AS severity and the 
severetity of AS should not be based on measurements of gradients 
alone. 
In a paper published by Antonini –Canterin et al (29)it has been 
observed that individuals with AS and systemic hypertension develop 
symptoms earlier and they do so at larger EOAs when compared to 
individuals with AS and without hypertension. 
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The concept of valvuloarterial impedance 
 The estimation of global hemodynamic load: the concept of 
valvuloarterial impedance  
Global hemodynamic load is the total load faced by the left 
ventricle. In patients with aortic stenosis the left ventricle has to eject 
agains a stenotic valve , but in case of patients with aortic stenosis and 
stiff aortas as in the elderly and the patients with as and coexisting 
hypertension the Left ventricle faces a double load the load constitutes 
the valvular plus the vascular load imposed by the aortic valve and the 
aorta respectively.It is difficult to quantitae this load accurately. 
Pibarot et al  have proposed a new index for the assesment of 
global hemodynamic load, known as the valvuloarterial impedance. This 
is an index that can be measured by Doppler echocardiography.(26) 
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The Valvuloarterial impedance (ZVa) is defined as the ratio of the 
estimated LV systolic pressure (the sum of systolic arterial pressure 
(SAP) and mean pressure gradient (MPG) to the stroke volume indexed 
(SVi) for body surface area:  
  
(The value is given in mm Hg/ml m²) 
This index represents both the vascular and the valve factors that 
impede left ventricular ejection by absorbing the kinetic energy (which 
is transformed to thermal energy) developed by the Left ventricle. 
This index gives us the cost in mmHg for every ml of blood 
pumped by the LV indexed for body area. 
Values of Zva  are usually <3.5  mm Hg/mL m²  
Zva value of 3.5 to 4.5 mm Hg/mL m² is considered to be 
moderately elevated  
Zva value of > 4.5 mm Hg/mL m² is considered to be highly 
elevated.  
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Many studies have been performed analyzing the impact of high 
valvuloarterial impedance in patients with aortic stenosis. (4,6,7)  High 
valves of Valvuloarterial impedance is associated with impaired LV 
function (both systolic and diastolic) and is also associated with 
decreased left ventricular  longitudinal, circumferential and radial strain 
patterns , this impairment is observed more frequently in patients with a 
low flow state with normal Left ventricular function (30) 
Patients with moderate degree of aortic stenosis and added 
hypertension have increased LV global load and this load may 
sometimes be larger than the load faced by the LV of the patient with 
Severe Aortic stenosis without hypertension. So the patient might 
develop myocardial dysfunction earlier and at lesser degrees of stenosis 
severity (28) 
This concept of global load the valvuloarterial impedance may be 
useful in a clinical point of view and this might be able to explain the 
discordance between the severity of Aortic stenosis  and the patients 
symptoms (ie moderate AS but with symptoms). In symptomatic 
patients with low ZVa values the symptoms might be attributed to 
another condition producing the symptom and in patients with moderate 
AS and high ZVa the symptoms and LV dysfunction can be explained 
by the additive effects of moderate Aortic valve stenosis and elevated 
vascular load of decreased arterial complaince.  
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In a retrospective study done by Hachica et al (6) in 544 patients 
with  asymptomatic Aortic stenosis of atleast moderate or severe 
grades,it was shown that elevated ZVa valvues is a marker of excessive 
LV global load.  increased valvuloarterial impedance (values above 3.5 
mm Hg/ml) was associated with poor outcomes.It was also found that 
there was graded relationship between elevated ZVa and reduced overall 
survival. 
In a prospective study done by Lancelloti et al in 163 patients 
with moderate to severe aortic stenosis it was noted that, elevated 
valvuloarterial impedance (≥5 mmHg/mL m²) was a powerful predictor 
of decreased cardiac event-free survival in patients with asymptomatic 
Aortic stenosis.(7) 
In a retrospective study done by Levy et al in 184 patients with 
symptomatic severe AS with low gradients and depressed LV function, 
48% of the study population had high Zva values (≥5.5 mmHg/ml/m²).  
when compared to their counterparts with low Zva values the persons 
with high values had significantly reduced ejection fraction , had lower 
LV end diastolic dimensions and had contractile reserve, but the Zva 
values were not different in patients having severe and pseudo severe 
AS. (31) 
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Pitfalls in the measurement of valvuloarterial impedance. 
The valvuloarterial impedance is a flow dependent parameter and 
it is subjected to change due to variations in flow even in the same 
patient over time and in case of an patient with a low flow AS subtle 
changes in flow might lead to variations. Two different patients with 
similar amount of hypertension and similar amount of valve area may 
have different values of Zva. 
The mean gradient which is a numerator in the calculation of 
valvuloarterial impedance is a flow dependent parameter hence the flow 
variability affects Zva values and it is more pronounced in low flow 
situations than in moderate or high flow states. So, minor variations in 
heart rate or stroke volume may bring about variations in Zva. Moreover 
in low flow conditions even a minor error in measurement of stroke 
volume may alter the Zva values. So calculation of Zva in low flow 
states might not be so useful. (26) 
But the valvuloarterial impedance has been demonstrated to be 
superior to other indices severity of Aortic stenosis (like the valve area 
and pressure gradients) in predicting worse clinical outcomes and in 
predicting LV dysfunction. (4) 
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Left ventricular dysfunction in aortic stenosis  
 According to the ACC/AHA and ESC guidelines for the 
management of valvular heart diseases, irrespective of their symptoms 
presence of left ventricular systolic dysfunction is a class I indication for 
valve replacement in aortic valve stenosis. And LVEF is the only index 
concerned with LV performance that is included in the treatment 
guidelines. Many studies have observed that in asymptomatic AS 
patients with normal ejection fraction, about 30% had significant 
disturbance in their intrinsic myocardial function. It has been noted that 
the measurement of LV longitudinal kinetics are better than other 
measures of systolic left ventricular function to identify  early 
myocardial  structural deterioration (5,33,34) 
The longitudinal contractile function of the left ventricle is 
governed by the subendocardial myocytes and these myocytes are more 
prone to ischemic damage due to their location. So In patients with 
aortic stenosis the left ventricular long axis function gets affected early 
in the course of the disease and at this stage the patient still has 
preserved left ventricular ejection fraction Left ventricular longitudinal 
function can be assessed using pulse wave Doppler imaging. In a study 
done by Takeda et al (32) using mitral annular plane systolic excursion as 
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a measure of long axis function it was shown that the long axis function 
was affected in aortic stenosis early even before reduction in ejection 
fraction or fractional shortening .  So assessment of MAPSE in Aortic 
stenosis will help us to identify myocardial dysfunction before the 
decrease in ejection fraction. (35) 
 
 
 
 
 
 
 
 
Picture showing the concept of LV dysfunction in aortic stenosis 
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Asymptomatic Aortic Stenosis 
Since aortic stenosis is common among elder population who 
restrict their activities, the incidence of asymptomatic aortic stenosis is 
higher among them. 
Identification of true asymptomatic aortic stenosis requires further 
evaluation. The minimum requirement is that they should be free of 
symptoms and have an aortic valve area of less than 1 cm2, they should 
have normal LV function and should have normal exercise tolerance. 
The incidence of sudden death in asymptomatic severe aortic 
stenosis is approximately less than 2% per year. But the surgical 
mortality of isolated aortic valve replacement is approximately 4%. So 
even in patients with asymptomatic severe aortic stenosis, only high risk 
patients are to be operated. (36) 
The progression of in asymptomatic valvular aortic stenosis is 
usually slow. The mean gradient increases by approximately 7 mm Hg 
per year and the decrease in orifice area is 0.1 cm2 per year. So they 
should be watched for the development of the symptoms or evidence of 
rapid progression which would direct them towards surgery. 
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Once the patient becomes symptomatic, life expectancy is very 
much reduced unless surgery is done. In this situation Exercise testing is 
useful 
Exercise testing in asymptomatic AS helps us to identify the 
asymptomatic persons with normal LV function who are candidates for 
surgery. Exercise testing in considered being positive if the patient 
develops symptoms, if there is a fall in blood pressure, if there is an 
increase in gradient or if there is development of complex 
arrhythmias.(37)  
The newer classification proposed for aortic stenosis is based on 
the indexed stroke volume and mean trans aortic gradient (flow and 
gradient).(38) 
Aortic stenosis can be classified into four categories 
 1. Normal flow - Low gradient 
 2. Normal flow - High gradient 
 3. Low flow - High gradient 
 4. Low flow - Low gradient 
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Normal flow is indexed stroke volume > 35 ml / m2 and low flow is < 35 
ml / m2  
High gradient is more than 40 mm Hg and low gradient is less than 40 
mm Hg. 
Comprehensive assessment in aortic stenosis 
With present information on the complex nature of aortic stenosis, 
the assessment of severity of aortic stenosis needs a more elaborate 
evaluation going beyond normal indices of severity such as gradients 
and effective orifice areas. The newer modalities that would be useful to 
risk stratify patients are the Energy loss index, the valvuloarterial 
impedance, the measurements of BNP levels and measurement of global 
longitudinal strain. In asymptomatic patients with normal LV function 
Exercise testing is useful. Recently CT and CMR have been proved to 
be useful in assessing the severity of aortic stenosis.(26) 
 
     
 
 
42 
MATERIALS AND METHODS 
Setting:  
 The study was performed in the Department of Cardiology, 
Madras Medical College, Chennai. 
Design of the study: Prospective analytical study 
Period of the Study:  Three months 
Sample size: 47 patients 
Ethical committee approval:  
 The present project was approved by the Institutional ethics 
committee. 
Inclusion criteria: 
 Patients attending Cardiology outpatient department and admitted 
in cardiology wards with moderate and severe aortic stenosis were 
included in the study. 
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Exclusion criteria: 
01.  Presence of mitral valve disease 
02.  Presence of more than mild aortic regurgitation 
03.  Previous history of coronary artery disease 
04.  Presence of moderate or severe LV systolic dysfunction 
05.  Chronic obstructive lung disease 
06. Arrhythmias including atrial fibrillation, supraventricular 
tachycardia or ventricular ectopics 
07.  Patients not willing to give consent  
Consent: 
 The study group thus identified by the above criteria (inclusion 
and exclusion criteria) was first instructed about the nature of the study. 
Willing participants were taken up after getting a written informed 
consent from them. 
Details of the study subjects: 
 A total of 47 patients attending cardiology outpatient department 
and admitted in cardiology ward with moderate to severe degrees of 
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isolated aortic stenosis were enrolled for the study if they fulfilled the 
inclusion and exclusion criteria. .  
Detailed history and physical examination were done. The symptoms of 
aortic stenosis such as dyspnoea, angina and syncope were recorded in 
detail. 
Physical examination included height, weight; Body Mass Index was 
calculated using Quetelet’s formula and Body Surface Area by Dubois 
formula.(BSA (m²) = 0.007184 x Height(cm)0.725 x Weight(kg)0.42) 
Blood Pressure Measurement 
Systemic blood pressure was measured in the echo lab during the time 
of measurement of derived stroke volume in left ventricular outflow 
tract. A properly calibrated mercury sphygmomanometer was used for 
this purpose. The arm cuff recordings were taken as standard 
measurements for all patients. The definition of Hypertension was 
according to JNC 7 guidelines. 
Echocardiography 
 Echocardiographic examination of the patients was done with 
Philips HD 7 XE machine. 2.5 mega HZ probe was used for trans-
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thoracic echocardiography. A complete trans-thoracic echocardiogram 
including M -mode, 2 D, Colour Doppler, Pulse and continuous wave 
Doppler and Tissue Doppler were done for every study participant. The 
measurements and indices were done according to the American society 
of Echocardiography guidelines. 
Echo Indices studied 
Indices of LV geometry 
 IVS thickness, Left ventricular posterior wall thickness, left 
ventricular internal dimensions in diastole, relative wall thickness was 
measured. Using these values the left ventricular mass and mass index 
were calculated. The LVOT diameter was also carefully measured in the 
parasternal long axis view with zoom in mode  
Mitral Annular Planar Systolic Excursion 
 Mitral annular motion is measured using M - mode 
echocardiography. Using apical four chamber view, M - mode cursor is 
aligned through lateral mitral annulus. M - Mode cursor should be 
parallel to the mitral annulus. The longitudinal displacement of the 
annulus from the base to the apex is measured.  
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Indices of Left ventricular systolic function 
Left ventricular ejection fraction was calculated using Simpson's method 
and Quinone's method and also by visual estimate. 
Indices of left ventricular diastolic function 
Diastolic function of the left ventricle was assessed using pulse 
wave Doppler to study the trans-mitral flow velocities and tissue 
Doppler study of the lateral mitral annulus was done and E/e' was also 
calculated. 
Indices of aortic stenosis severity 
The Doppler parameters that where studied included the gradient 
across the aortic valve using continuous wave Doppler the mean 
gradient and the peak gradient were and the aortic valve VTI were 
obtained. Using pulsed wave Doppler in the LVOT the VTI was 
obtained. Using these values the aortic valve area is calculated by using 
the continuity equation.   
Stroke volume calculation  
Stroke Volume = LVOT area x LVOT VTI, 
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 LVOT area was calculated using the LVOT diameter. Stroke volume 
index was calculated  
Myocardial Performance Index 
 To obtain LV Tei index, pulse wave Doppler recording of the 
mitral valve inflow and left ventricular outflow is recorded. The 
duration from the end of A wave of the mitral valve inflow to the 
starting of the E wave of the mitral inflow is measured. This is taken as 
total contraction time. The ejection time is measured from the left 
ventricular outflow tracing. The isovolumic time is calculated by 
subtracting ejection time from total contraction time. Isovolumic time 
divided by ejection time gives the myocardial performance index. 
Calculation of Valvuloarterial impedance :( 26) 
Valvuloarterial impedance (Zva) was calculated using the formula  
 (Zva) = (systolic blood pressure + mean transvalvular gradient)/stroke 
volume index. 
Statistical Analysis: 
 The collected data was tabulated in Microsoft excel spread sheet 
and statistical analysis of the data was done using Statistical Package for 
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Social Sciences software (SPSS version 17.0). Categorical data are 
presented as absolute values and percentages, whereas continuous data 
are summarized as mean value ± SD. Independent sample‘t’ test and Chi 
- square tests were used for comparison of categorical variables as 
appropriate. Significance was considered if the ‘p’ value was below 
0.05.Analysis of variance (ANOVA) was used to analyze the difference 
between group means. 
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RESULTS AND DATA ANALYSIS 
In this study, 47 patients with moderate and severe aortic stenosis 
without significant aortic regurgitation were studied. 
Out of the 47 patients 15 were females (32%), Male gender was 
the predominant gender that was found to be affected with Aortic 
Stenosis (68% vs. 32%) 
The age group of the study population ranged from 32 to 81 years 
and the mean age of the study population was 58.55 + 9.760 years. The 
average age of presentation of Aortic Stenosis in our study population 
was in the sixth decade and 72% (34 out of 47) patients were in the age 
group of 50 to 70 years. 
The age group distribution of the study population is as follows  
Age group (in years) No of persons 
< 40 2 
40 to 50 5 
50 to 60 19 
60 to 70 15 
>70 6 
Total 47 
 
 
Age wise distribution of patients
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Age wise distribution 
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Sex wise distribution 
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Chart 1 
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The observations related to patient history are as follows   
In the study population 38% of the patients had previous history 
of hypertension and 40 % of the patients had Diabetes Mellitus and only 
4% of the patients had a history of Rheumatic heart disease. 38% of the 
patients were Smokers. 
History No of patients 
Hypertension 18 (38%) 
Diabetes mellitus 19 (40%) 
Previous RHD 2 (4%) 
Smoking 18(38%) 
 
Bicuspid Aortic valve stenosis 
 Out of the 47 patients studied 4 patients (9%) had Bicuspid Aortic 
valve, the mean age of the patients in this subgroup was 41±7.07 years 
when compared to the total population mean age of 58.55 + 9.760 years 
this group had a significantly lower mean age.  
 The patients were classified into 3 groups based on the values of 
valvuloarterial impedance (Zva) for statistical analysis. 
Group Zva (in mmHg/ml/m2) No of patients 
Low Zva < 3.5 16 (34%) 
Medium Zva 3.5 to 4.4 18(39%) 
High Zva ≥4.5 13(27%) 
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Chart 3 
Patient history 
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Zva groups  
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 Patients with valvuloarterial impedance levels of < 3.5 
mmHg/ml/m2 were named as the “Low Zva” group they consisted of 
34% of the total study population. those with valvuloarterial impedance 
levels of 3.5 to 4.4 mmHg/ml/m2 were named as the Medium “Zva 
group” and they consisted of 39% of the study population , those with 
Zva levels of ≥4.5 mmHg/ml/m2 were named as the “High Zva” group 
and they consisted of 27% of the total study population. The clinical and 
Echocardiographic variables were compared among these groups using 
Analysis of Variance. 
 The baseline characteristics of the study population according to 
the 3 groups is as follows 
Patient Related factors and Zva 
Group Low 
Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) 
P value 
Age (in years ) 52.81±7.44 57.83±6.71 66.62±10.81 < 0.001 
Female gender 4(25%) 5(28%) 4(31%) 0.942 
BMI (kg/m2) 23.04±2.98 24.84±2.93 24.19±2.49 0.187 
BSA (m2) 1.73±0.19 1.77±0.17 1.74±0.16 0.699 
Hypertension 3(19%) 8(44%) 7(54%) 0.122 
DM 8(50%) 5(28%) 6(46%) 0.371 
Smoking 7(44%) 7(39%) 4(30%) 0.773 
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 When comparing the three groups the mean age in the low 
Zva group was 52.81±7.44 years  and the mean age of the high Zva 
group was 66.62±10.81 years the patients with  high Zva were 
significantly older (p<0.001) than the medium and the low Zva groups. 
 The distribution of females in the three groups was similar 
and there was no statistically significant difference between the three 
groups with respect to gender. 
The Body mass index and body surface area were comparable 
between the three groups and there was no statistically significant 
difference. 
The percentage of patients with history of hypertension was 19% 
in the low Zva group 44% in the medium Zva group and 54% in the 
high Zva group. When compared to the low Zva group the persons in the 
medium and high Zva had a higher prevalence of systemic hypertension.  
There was no statistically significant difference between the low, 
medium and high Zva groups with regard to diabetes mellitus and 
smoking. 
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Vascular and Valvular factors and Zva 
Group Low Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) P value 
Systolic BP (mm Hg) 123.63±21.20 130.78±12.39 146.77±10.94 0.001 
Diastolic BP (mm Hg) 82.38±13.70 80.67±7.39 80.31±6.72 0.826 
Pulse pressure  41.25±12.22 50.11±8.44 66.46±9.70 <0.001 
AVA (cm2) 1.26±0.18 1.25±0.19 0.96±0.15 <0.001 
Peak gradient (mm Hg) 68.62±18.21 63.67±8.13 79.92±10.72 0.005 
Mean gradient (mmHg) 42.64±13.54 43.94±11.03 51.76±12.15 0.114 
Zva (mmHg/ml/m2) 2.94±0.41 3.90±0.29 5.68±0.70 <0.001 
  
Blood pressure  
The patients with high Zva values had a significantly higher 
systolic blood pressure when compared to patients with lower Zva 
values. The mean systolic blood pressure in the high Zva group was 
146.77±10.94 as against 130.78±12.39 in the medium Zva group and 
123.63±21.20 in the low Zva group and this difference was statistically 
significant (p=0.001) .There was no statistically significant difference in 
diastolic blood pressure between the three groups. The pulse pressure as 
expected was significantly higher in persons with high Zva values 
(p<0.001) indicating that the patients in the higher Zva group had a 
higher level of vascular load. 
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Aortic valve indices  
The parameters used to quantify the severity of stenosis are the 
Aortic valve area, the mean gradient across the stenotic aortic valve and 
the peak gradients. Patients with high Zva values had a significantly 
reduced Aortic valve area when compared to the lower Zva value 
groups. The mean aortic valve area in the high Zva group was 0.96±0.15 
compared to 1.26±0.18 in the low Zva group (p<0.001). 
The peak gradients were significantly higher in the High Zva 
groups. (79.92±10.72 compared to 63.67±8.13, p value 0.005) 
The mean gradients were higher in the high Zva group but this 
difference was not statistically significant. Mean gradient is one of the 
measures for the classification of Aortic stenosis severity the ACC/AHA 
and ESC have defined different mean gradient values for classification 
of severity. The values for mean gradient is 20 to 40 mmHg 
(ACC/AHA) [30to 50 mmHg for ESC] for moderate severity and above 
50mm Hg (ACC/AHA) [>50 mmHg for ESC] for severe aortic stenosis. 
In this study the mean gradient values suggested by ACC/AHA were 
adopted, patients in the High Zva group had a mean gradient value of 
51.76±12.15 mmHg and the mean gradient of the medium and low Zva 
groups were 43.94±11.03 mmHg and 42.64±13.54 mmHg respectively.  
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Echo images 
 
 
 
 
 
 
 
 
 
 
 
Continuous wave Doppler showing mean gradient 51.6mm Hg and peak gradient 
100mmHg 
 
 
 
 
 
 
 
Measurement of LVOT  VTI 
 
 
 
 
 
 
 
 
 
 
 
Parasternal short axis view at aortic level showing calcific aortic valve 
 
58 
Based on ACC recommendations all the three groups would 
classify as severe Aortic Stenosis. Conversely if the ESC guidelines cut 
off values were used it will come to light that the High Zva group would 
have gradients which would classify them as severe and the Medium 
and low Zva patients would be classified as having Moderate Aortic 
stenosis severity. This shows that even if not statistically significant the 
patients in high Zva group had a difference in gradient of 8 mmHg. 
LV geometry indices and Zva 
Group Low 
Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) 
P value 
IVS (cm) 1.67±0.31 1.68±0.23 1.92±0.35 0.046 
LVPW(cm) 1.58±0.31 1.56±0.22 1.81±0.35 0.063 
LVIDd(cm) 4.26±0.59 4.48±0.78 3.84±0.47 0.033 
RWT 0.78±0.19 0.75±0.20 0.98±0.22 0.008 
 
The indices of Left ventricular geometry that were studied were 
the thickness of the interventricular septum, the left ventricular posterior 
wall and the relative wall thickness.The Left ventricular internal 
dimensions in diastole was also studied. The observations showed that 
there was a statistically significant difference between the three groups 
in terms of LV geometry. But the patients with High Zva had thicker 
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ventricles (approximately 3mm, p = 0.046), smaller LV cavity 
(approximately 14mm, p=0.033) and higher relative wall thickness 
(approximately 0.18, p=0.008) than the medium and low Zva groups.  
LV function indices and Zva 
Group Low 
Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) 
P value 
LVEF (%) 60.13±8.19 58.39±5.46 63.08±6.37 0.173 
Stroke Vol 
(ml) 
100.00±22.45 79.89±10.13 61.57±9.97 <0.001 
SVi 57.94±11.46 44.94±3.67 35.31±3.84 <0.001 
E/e’ 11.48±4.20 11.85±3.31 14.22±4.31 0.145 
Tei index .036 0.39 0.41 0.136 
 
Patients with high Zva values had a statistically significantly 
lower stroke volume and stroke volume index when compared to the 
lower Zva groups. There was no significant difference in Left 
ventricular ejection fraction between the three groups. 
LV diastolic dysfunction and Zva  
LVDD Low Zva(n=16) 
Medium  
Zva(n=18) 
High 
Zva(n=13) P value 
Grade 1 6 8 2 
 
0.032 
Grade 2 1 15 2 
Grade 3 3 5 5 
Total 10 28 9 47 
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All the patients in the study population had diastolic dysfunction 
and the grades of diastolic dysfunction were significantly higher in 
patients with high Zva values. 
Mitral E/e’ velocities were above the normal value of 8 in all the 
three groups implying that all the study patients had mildly elevated 
filling pressures and moderate degrees of left ventricular diastolic 
dysfunction. 
The left ventricular Tei index was calculated as a measure of 
global LV function and there was no significant difference in Tei index 
between the three groups. 
Symptoms of AS and Zva 
Group Low Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) P value 
SOB 7(43%) 11(61%) 8(61%) 0.518 
Angina 5(31%) 5(28%) 3(23%) 0.887 
Syncope 2(12%) 2(11%) 6(46%) 0.036 
Giddiness 6(37%) 4(22%) 3(23%) 0.555 
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Out of the total 47 patients studied 37 patients had one or 
combination of symptoms, of the symptoms Shortness of breath was the 
commonest symptom in three groups and the symptoms of SOB, 
Angina, and giddiness were similar in all the three groups. 
Syncope 
The incidence of syncope was significantly higher in the High 
Zva group (46%, p=0.036) showing a positive association between high 
Zva value and syncope. 
MAPSE (longitudinal LV function) and Zva 
Group Low Zva(n=16) 
Medium 
Zva(n=18) 
High 
Zva(n=13) P value 
MAPSE (mm) 10.91±1.51 10.43±0.77 9.26±0.81 0.001 
 
Mitral annular plane systolic excursion of the lateral mitral 
annulus was studied as a measure of LV longitudinal function our 
observation showed that in spite of normal LV function in the High Zva 
group the MAPSE was significantly lower (p=0.001) indicating that LV 
long axis function was affected.    
 
 
Symptomatic vs. Asymptomatic
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Chart 5  
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Asymptomatic AS  
Out of the sample population of 47 patients, 34 patients had either 
or combination of symptoms of SOB, Angina, Syncope or Giddiness.13 
patients were asymptomatic. 
Symptomatic AS vs Asymptomatic AS  
Patient variables  
Group Symptomatic AS Asymptomatic AS P Value 
Age 58.15±11.18 59.62±4.42 0.650 
Female Sex (n=13) 8(61%) 5(39%) 0.304 
BMI 23.93±2.78 24.35±3.21 0.662 
BSA 1.75±0.17 1.74±0.17 0.910 
Hypertension 
(n=18) 
13(72%) 5(28%) 0.989 
Diabetes (n=19) 16(84%) 3(16%) 0.134 
Smoking(n=18) 16(89%) 2(11%) 0.046 
 
 There was no significant difference between Asymptomatic AS 
patients and symptomatic patients with respect to Age, Gender, Body 
Mass Index, Body Surface Area, Hypertension or DM. 
 Smokers had a significantly high incidence of symptoms 
(p=0.046) 
64 
Vascular and Valvular load indices and symptoms 
Group Symptomatic AS Asymptomatic AS P Value 
Systolic BP 131.47±18.37 136.15±16.82 0.429 
Pulse pressure 50.29±13.67 55.08±15.33 0.305 
Diastolic BP 81.18±9.71 81.08±10.05 0.975 
Aortic valve area 1.17±0.21 1.17±0.24 0.929 
Peak gradient 69.64±14.91 70.38±13.42 0.877 
Mean gradient 45.16±12.64 47.00±12.82 0.658 
Zva 3.90±.12 4.51±1.27 0.117 
MAPSE 10.19±1.36 10.50±0.90 0.450 
 
There was no significant difference between the symptomatic 
patients and asymptomatic patients with respect to vascular factors such 
as systolic blood pressure, pulse pressure and valvular factors such as 
aortic valve area and gradients. MAPSE in both groups was comparable. 
The values of valvuloarterial impedance (Zva) were higher in 
asymptomatic patients (mean Zva in asymptomatic patients was 
4.51±1.27 mmHg/ml/m2 compared to 3.90±.12 mmHg/ml/m2) but this 
difference was not statistically significant (p=0.117) 
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Indices of LV geometry, LV function and symptoms 
Group Symptomatic AS Asymptomatic AS P Value 
IVS 1.71±0.30 1.83±0.31 0.239 
LVPW 1.60±0.32 1.73±0.25 0.175 
LVIDd 4.36±0.72 3.88±0.42 0.029 
RWT 0.79±0.23 0.92±0.17 0.055 
LVEF 58.50±6.96 64.92±3.88 0.003 
Stroke Vol 84.36±22.51 74.64±17.24 0.167 
SVi 48.15±12.00 42.92±9.68 0.168 
E/e’ 12.60±4.24 11.80±3.38 0.543 
Tei index 0.40±0.07 0.34±0.04 0.010 
 
When comparing the indices of LV geometry and function 
between the symptomatic patients and asymptomatic patients there was 
no significant difference between the two groups in terms of Left 
ventricular wall thickness, stroke volume and stroke volume index, 
diastolic dysfunction and Tei index. 
Asymptomatic patients had significantly lower LV internal 
diastolic dimensions (3.88±0.42 cm in asymptomatic vs.  4.36±0.72 cm 
in symptomatic) (p=0.029) 
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Asymptomatic patients also had significantly higher ejection 
fraction (64.92±3.88% in asymptomatic vs. 58.50±6.96% in 
symptomatic) (p=0.003) 
Paradoxical low flow pattern in which stroke volume index is less 
than  35ml/min/m2 and LV ejection fraction ≥50% was found in 6 
patients(46%) with high Zva values (Zva >4.5 mmHg/ml/m2) and none 
of the patients in the medium or low Zva group had paradoxical low 
flow pattern. 
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DISCUSSION 
This study was performed with the aim of evaluating the levels of 
valvuloarterial impedance in aortic stenosis in the south Indian 
population. The symptoms of aortic stenosis, indices of LV geometry, 
LV function and Aortic valve stenosis severity were correlated with the 
levels of valvuloarterial impedance. 
Based on the values of valvuloarterial impedance (Zva) the 
patients were classified into three groups, the group with Zva values 
below 3.5 mmHg/ml/m2 were classified as the Low Zva group, the Zva 
values from 3.5 to 4.5 mmHg/ml/m2 were classified as Medium Zva 
group and Zva 4.5 mmHg/ml/m2 and above were classified as the High 
Zva group. 
Age and valvuloarterial impedance  
 Aortic stenosis is considered to be disease of the elderly. Since 
Aortic stenosis and the reduced aortic compliance share the same 
degenerative and inflammatory etiology it is logical for elderly 
individuals to have stiffer aortas and hence elevated Zva values. (1) In 
this study the average age in patients participating in the study was 
58.55±9.76 years and presenting with high Zva values was 66.62±10.81 
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years. The individuals in the high Zva group were older than their 
counterparts. 
In a two separate studies   done by Hachicha et al(6) and Ashild E 
Reick et al (39)it has been shown that the mean age of patients with aortic 
stenosis is high and was around 68 to 70 years, in our study the mean 
age of the patients was 58 years which shows that the mean age of 
patients presenting with calcific aortic valve disease is lesser in our 
population. In the high Zva group the mean age of the patients was 
higher, it has been proved that older patients have more degenerative 
changes occurring in the vascular system and have stiffer aortas hence 
they are prone to have higher systolic BP and stiff arteries. 
 In our study population the mean age in the high Zva group was 
significantly higher than in the lower Zva groups and it was comparable 
to the study done by Hachicha et al and Ashild E Reick et al where the 
mean age group in patients with high Zva was 73 years 
 It is known that hypertension is a common association with aortic 
stenosis and it has been shown in studies that the incidence of 
hypertension in aortic stenosis varies from 86% in various studies (4, 40, 41) 
.In our study the history of hypertension was given by 38% of patients 
and actually 42% of patients were found to be hypertensive. This is 
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comparable observations made in other studies. It has been observed 
that both systolic and diastolic blood pressure is higher in individuals 
with high Zva but in our study only the systolic BP had correlation with 
high Zva levels.  
Gatzka et al (42) have observed that women have stiffer blood 
vessels than males of comparable age and this results in higher 
impedance values, but in our study female gender did not have elevated 
Zva values.  
The Zva values when compared to indices of LV geometry 
showed that the persons with high Zva values had a higher incidence of 
LV hypertrophy and lower cavity dimensions this is consistent with the 
findings of the observations made by Hachicha et al(6) and observations 
made in the SEAS trial subset(39) of patients with Aortic stenosis. 
Cioffi et al in their study(43) have reported  that the adverse 
outcomes in patients with aortic stenosis are higher if  LV hypertrophy 
indices are >110% of the expected values for sex, body mass and wall 
stress so the higher incidence of left ventricular hypertrophy in patients 
with high Zva will pave way for increased incidence of adverse 
outcomes. 
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Observations from the study done by Cramariuc D et al (5) show 
that about 30% of patients with Aortic stenosis have reduced stroke 
volume but have a normal LV ejection fraction, this leads to a lesser 
transvalvular pressure gradient and the blood pressure might appear 
normal even if hypertension is present, sometimes based on gradient 
levels the severity may be falsely estimated as low and in reality these 
are the group of patients who are in an advanced state of disease 
progression. 
This low flow state is common in patients with high 
valvuloarterial impedance levels in our study population 46% of patients 
in the high Zva group had a low flow state compared to none in other 
groups. 
Syncope  
The occurrence of Syncope in Aortic stenosis carries a poor 
prognosis. Patients with aortic stenosis have a life expectancy of 2 years 
is the condition is left untreated. Severity of Aortic stenosis was 
considered to be the predictor of syncope but it was observed that not all 
patients with severe aortic stenosis had syncope so other factors were 
also thought to play a role in the development of syncope. In an article 
published by Harada K et al in 2013(44) in a study done in 451 patients 
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with aortic stenosis, it was shown that even a few patients with moderate 
aortic stenosis had evidence of syncope and of the total study population 
18% had reported syncope.  Multivariate analysis it showed that of all 
the indices only elevated Zva values were predictors of syncope. In that 
study ROC analysis identified that valvuloarterial impedance values 
above 4.7mm Hg/ml/m2 had more incidence of syncope. 
In our study patients occurrence of syncope had a statistically 
significant association with high levels of valvuloarterial impedance and 
46% of patients with Zva levels ≥ 4.5 mmHg/ml/m2 had syncope. It 
suggests that high levels of valvuloarterial impedance but not stenosis 
severity, helps in the identification of patients prone to develop syncope. 
Mitral Annular Planar Systolic Excursion and Left ventricular 
Function in Aortic Stenosis 
In a study done by Joanna Luszczak et al, it has been shown that 
mitral annulus planar systolic excursion is a better indicator of 
longitudinal left ventricular systolic dysfunction and it is comparable to 
speckle tracking echocardiography. (35) 
So this modality can be used for the assessment of early left 
ventricular systolic dysfunction in patients with normal ejection fraction. 
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Cramaruic et al has shown in his study(5) published in JACC 
imaging 2009 that one out of three individuals with asymptomatic aortic 
stenosis and normal LV ejection fraction had significant left ventricular 
dysfunction as demonstrated by decreased stress corrected shortening of 
the mid wall.(5) 
So in this context, the ejection fraction tends to under estimate the 
level of myocardial dysfunction in concentric left ventricular 
hypertrophy which is present in most cases of the aortic stenosis.  
So measurement of MAPSE in patients with aortic stenosis and 
normal LV function can give us an idea of the left ventricular 
dysfunction which is masked by the alteration in the geometry of the left 
ventricle. 
In our study mitral annular plane systolic excursion levels were 
found to be significantly lesser (9.26±0.81 mm) in patients with high 
Zva levels (Zva ≥4.5mmHg/ml/m2 ) but the LV ejection fraction in the 
same group patients was within normal limits (63.08±6.37%),this 
finding is similar to that seen in the previous studies and suggests that 
patients with Aortic stenosis in spite of having normal LV function have 
intrinsic myocardial dysfunction as evidenced by the reduction in long 
axis function of the heart. 
73 
Aortic stenosis severity and valvuloarterial impedance  
Resistance to LV ejection occurs at two levels in Aortic stenosis, 
one at the level of the valve and the other above this (at the level of the 
arteries) since valvuloarterial impedance is a composite of both these 
values it would be logical to presume that increase in aortic stenosis 
severity would result in an increase in severity of valvuloarterial 
impedance. In our study patients with high valvuloarterial impedance 
had significantly reduced aortic valve areas and higher peak gradients. 
Asymptomatic Aortic stenosis 
Management of asymptomatic aortic stenosis is a matter of 
debate, guidelines regarding the management of asymptomatic aortic 
stenosis recommend that asymptomatic aortic stenosis patients with LV 
dysfunction benefit from surgical management, in patients who restrict 
their activity might not have symptoms and if the symptoms are 
equivocal then exercise testing might help us to risk stratify them and 
suggest appropriate therapy. Some studies have shown that a subset of 
patients with severe AS have normal LV function and normal exercise 
test results management of these patients is challenging. Three recent 
studies have shown that the surgically treated asymptomatic severe 
aortic patients had better survival than their medically treated 
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counterparts. In this context assessment of severity of Aortic stenosis 
needs yet another index which would help in risk stratification, and a 
study done by Hachicha et at has suggested that in this situation 
Exercise testing may be useful when combined with elevated levels of 
Zva to direct patients toward early surgery.(6) 
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CONCLUSIONS 
Among the symptoms of Aortic stenosis, only Syncope had 
significant association with high levels of valvuloarterial impedance.  
 Older patients with aortic stenosis had significantly higher 
valvuloarterial impedance values due to a less compliant arterial system. 
In patients with Aortic stenosis higher systolic blood pressure and 
pulse pressure had a significant association with high levels of 
valvuloarterial impedance 
The patients with high levels of valvuloarterial impedance had 
significantly altered LV geometry as evidenced by thicker ventricles and 
smaller LV cavity dimensions. 
There was no significant difference in LV systolic function 
indices between the lower and higher valvuloarterial impedance groups. 
All the patients in this study group had LV diastolic dysfunction 
and higher grades of diastolic dysfunction were seen in patients with 
high valvuloarterial impedance levels. 
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The Mitral annular plane systolic excursion (MAPSE) was 
significantly decreased in patients with patients with higher levels of 
valvuloarterial impedance suggesting the presence of intrinsic 
myocardial longitudinal dysfunction in spite of preserved LV ejection 
fraction. 
There was a significant correlation between higher valvuloarterial 
impedance levels and lower aortic valve area and higher aortic valve 
peak gradients.  
There were no significant differences between Doppler 
characteristics between asymptomatic and symptomatic patients with 
aortic stenosis except for LV ejection fraction which was higher in the 
asymptomatic group. 
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LIMITATIONS OF THE STUDY 
Arm cuff pressure recordings were made in all the patients but 
invasive intra-arterial measurements would have been more accurate, 
but invasive recordings were not done due to patient and logistic issues. 
But in a study published in Archives of cardiovascular diseases 2010 has 
shown that the invasive measurements of blood pressure did not add to 
the predictive ability of valvuloarterial impedance. (30) 
Stroke volume calculation was done using the LVOT diameter 
and it was subject to variability and the calculation also assumes the 
LVOT to be circular which in reality is not. But in a study done by 
Juliane Lauten et al (45) it was reported that echo estimates of stroke 
volume were only slightly higher than invasive measurements. 
In contrast to western countries where isolated degenerative aortic 
stenosis is common the individuals presenting with isolated aortic 
stenosis were less in our hospital so the sample size was less limiting 
statistical accuracy. 
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CLINICAL AND ECHOCARDIOGRAPHIC CORRELATES OF VALVULO-
ARTERIAL IMPEDANCE IN AORTIC STENOSIS WITH FOCUS ON 
ASYMPTOMATIC AORTIC STENOSIS. 
PROFORMA 
NAME  :                                              AGE/SEX: 
IP / OP NO.                                            ADDRESS : 
Mode of referral    : 
Whether Previously known AS- if yes for how long?: 
Hypertension : 
Diabetes: 
CAD: 
RHD/Prev RF: 
Smoking/Tobacco use: 
Alcohol: 
Prev Surgery: 
Pulse Rate  
Blood Pressure : 
Systolic: 
Diastolic:  
Pulse Pressure: 
Height(cm): 
Weight(kg): 
Body mass Index: 
Body Surface Area (Dubois Method): 
Symptoms: 
Shortness of breath : 
Chest Pain : 
Syncope: 
Giddiness /Presyncope: 
Fatigue: 
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Other Symptoms: 
No Symptoms: 
Echocardiography 
Aortic stenosis 
LVOT VTI: 
LVOT dia:  
LVOT peak velocity: 
Aortic valve VTI: 
Aortic valve peak velocity: 
Aortic valve area: 
Peak Gradient: 
Mean gradient: 
LV geometry 
IVSd: 
LVPWd: 
LVEDV: 
LVIDd 
LVIDs: 
Relative Wall thickness: 
LVEF: 
FS%: 
Stroke Volume:  
Stroke volume index: 
LV diastolic function 
Mitral E: 
Mitral A: 
E/A: 
Tissue doppler 
E': 
E/E': 
MAPSE: 
LV Tei Index: 
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அறிuni0BA8_uni0BCDuni0BA4_uni0BC1 ெகாuni0BA3_uni0BCDேடuni0BA9_uni0BCD. 
இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDuni0BB5_uni0BC1 சuni0BAE_uni0BCDமuni0BA8_uni0BCDதமாகuni0BB5_uni0BC1uni0BAE_uni0BCD, ேமuni0BB2_uni0BC1uni0BAE_uni0BCD இuni0BA4_uni0BC1 சாuni0BA8_uni0BCDதஆuni0BAF_uni0BCDuni0BB5_uni0BC1 ேமuni0BB1_uni0BCDெகாuni0BB3_uni0BCDuni0BB3_uni0BC1uni0BAE_uni0BCDேபாuni0BA4_uni0BC1uni0BAE_uni0BCD, இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDவிuni0BB2_uni0BCD 
பuni0B99_uni0BCDuni0B95_uni0BC1ெபuni0BB1_uni0BC1uni0BAE_uni0BCD மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வ எuni0BA9_uni0BCDuni0BA9_uni0BC1ைடய மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வ அறிuni0B95_uni0BCDைககைளuni0BAA_uni0BCD பாuni0BAA_uni0BCDபதuni0BB1_uni0BCDuni0B95_uni0BC1 எuni0BA9_uni0BCD அuni0BA9_uni0BC1மதி ேதைவயிuni0BB2_uni0BCDைல 
என அறிuni0BA8_uni0BCDuni0BA4_uni0BC1ெகாuni0BB3_uni0BCDகிேறuni0BA9_uni0BCD. நாuni0BA9_uni0BCD ஆuni0BAF_uni0BCDவிuni0BB2_uni0BCD இuni0BB0_uni0BC1uni0BA8_uni0BCDuni0BA4_uni0BC1 விலகிuni0B95_uni0BCD ெகாuni0BA3_uni0BCDடாuni0BB2_uni0BC1uni0BAE_uni0BCD இuni0BA4_uni0BC1 ெபாuni0BB0_uni0BC1uni0BA8_uni0BCDuni0BA4_uni0BC1uni0BAE_uni0BCD என அறிகிேறuni0BA9_uni0BCD. 
இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDவிuni0BA9_uni0BCD uni0BAE_uni0BC2லuni0BAE_uni0BCD கிைடuni0B95_uni0BCDuni0B95_uni0BC1uni0BAE_uni0BCD தகவuni0BB2_uni0BCDகைளuni0BAF_uni0BC1uni0BAE_uni0BCD, ப/ேசாதைன uni0BAE_uni0BC1uni0B9F_uni0BBFuni0BB5_uni0BC1கைளuni0BAF_uni0BC1uni0BAE_uni0BCD மuni0BB1_uni0BCDuni0BB1_uni0BC1uni0BAE_uni0BCD சிகிuni0B9A_uni0BCDைச 
ெதாடபான தகவuni0BB2_uni0BCDகைளuni0BAF_uni0BC1uni0BAE_uni0BCD மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வ ேமuni0BB1_uni0BCDெகாuni0BB3_uni0BCDuni0BB3_uni0BC1uni0BAE_uni0BCD ஆuni0BAF_uni0BCDவிuni0BB2_uni0BCD பயuni0BA9_uni0BCDபuni0B9F_uni0BC1uni0BA4_uni0BCDதிuni0B95_uni0BCD ெகாuni0BB3_uni0BCDளuni0BB5_uni0BC1uni0BAE_uni0BCD, அைதuni0BAA_uni0BCD 
பிரuni0B9A_uni0BC1/uni0B95_uni0BCDகuni0BB5_uni0BC1uni0BAE_uni0BCD எuni0BA9_uni0BCD uni0BAE_uni0BC1uni0BB4_uni0BC1 மனuni0BA4_uni0BC1டuni0BA9_uni0BCD சuni0BAE_uni0BCDமதிuni0B95_uni0BCDகிேறuni0BA9_uni0BCD. 
இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDவிuni0BB2_uni0BCD பuni0B99_uni0BCDuni0B95_uni0BC1 ெகாuni0BB3_uni0BCDள ஒuni0BAA_uni0BCDuni0BAA_uni0BC1uni0B95_uni0BCDெகாuni0BB3_uni0BCDகிேறuni0BA9_uni0BCD. எனuni0B95_uni0BCDuni0B95_uni0BC1uni0B95_uni0BCD ெகாuni0B9F_uni0BC1uni0B95_uni0BCDகuni0BAA_uni0BCDபuni0B9F_uni0BCDட அறிuni0BB5_uni0BC1ைரகளிuni0BA9_uni0BCD பuni0B9F_uni0BBF 
நடuni0BA8_uni0BCDuni0BA4_uni0BC1ெகாuni0BB3_uni0BCDவuni0BA4_uni0BC1டuni0BA9_uni0BCD, இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDைவ ேமuni0BB1_uni0BCDெகாuni0BB3_uni0BCDuni0BB3_uni0BC1uni0BAE_uni0BCD மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வ அணிuni0B95_uni0BCDuni0B95_uni0BC1 உuni0BA3_uni0BCDைமuni0BAF_uni0BC1டuni0BA9_uni0BCD இuni0BB0_uni0BC1uni0BAA_uni0BCDேபuni0BA9_uni0BCD எuni0BA9_uni0BCDuni0BB1_uni0BC1uni0BAE_uni0BCD 
உuni0BB1_uni0BC1தியளிuni0B95_uni0BCDகிேறuni0BA9_uni0BCD. எuni0BA9_uni0BCD உடuni0BB2_uni0BCD நலuni0BAE_uni0BCD பாதிuni0B95_uni0BCDகuni0BAA_uni0BCDபuni0B9F_uni0BCDடாேலா அuni0BB2_uni0BCDலuni0BA4_uni0BC1 எதிபாராத வழuni0B95_uni0BCDகuni0BA4_uni0BCDதிuni0BB1_uni0BCDuni0B95_uni0BC1 மாறாக 
ேநாuni0BAF_uni0BCDuni0B95_uni0BCDuni0B95_uni0BC1றி ெதuni0BA9_uni0BCDபuni0B9F_uni0BCDடாேலா உடேன அைத மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வ அணியிடuni0BAE_uni0BCD ெத/விuni0BAA_uni0BCDேபuni0BA9_uni0BCD என உuni0BB1_uni0BC1தி அளிuni0B95_uni0BCDகிேறuni0BA9_uni0BCD. 
இuni0BA8_uni0BCDத ஆuni0BAF_uni0BCDவிuni0BB2_uni0BCD எனuni0B95_uni0BCDuni0B95_uni0BC1 மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வuni0BAA_uni0BCD ப/ேசாதைன, இரuni0BA4_uni0BCDதuni0BAA_uni0BCD ப/ேசாதைன மuni0BB1_uni0BCDuni0BB1_uni0BC1uni0BAE_uni0BCD இதய உuni0BA4_uni0BCDuni0BAA_uni0BC1uni0B95_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1 
சிகிuni0B9A_uni0BCDைச ப/ேசாதைன ெசuni0BAF_uni0BCDuni0BA4_uni0BC1 ெகாuni0BB3_uni0BCDள நாuni0BA9_uni0BCD uni0BAE_uni0BC1uni0BB4_uni0BC1 மனuni0BA4_uni0BC1டuni0BA9_uni0BCD சuni0BAE_uni0BCDமதிuni0B95_uni0BCDகிேறuni0BA9_uni0BCD. 
 
பuni0B99_uni0BCDேகuni0BB1_uni0BCDபவ/uni0BA9_uni0BCD ைகெயாuni0BAA_uni0BCDபuni0BAE_uni0BCD ....................................................................  இடuni0BAE_uni0BCD .............................................. ேததி ........................ 
கuni0B9F_uni0BCDைடவிரuni0BB2_uni0BCD ேரைக: 
பuni0B99_uni0BCDேகuni0BB1_uni0BCDபவ/uni0BA9_uni0BCD ெபய மuni0BB1_uni0BCDuni0BB1_uni0BC1uni0BAE_uni0BCD விலாசuni0BAE_uni0BCD ................................................................................................................................................... 
ஆuni0BAF_uni0BCDவாள/uni0BA9_uni0BCD ைகெயாuni0BAA_uni0BCDபuni0BAE_uni0BCD .......................................................................... இடuni0BAE_uni0BCD .................................................ேததி ..................... 
ஆuni0BAF_uni0BCDவாள/uni0BA9_uni0BCD ெபய .......................................................................................... 
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ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசி தகவuni0BB2_uni0BCD தாuni0BB3_uni0BCD 
ெசuni0BA9_uni0BCDைன அரuni0B9A_uni0BC1 ெபாuni0BA4_uni0BC1 மuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1வமைனயிuni0BB2_uni0BCD ெபuni0BB0_uni0BC1uni0BA8_uni0BCDதமணி வாuni0BB2_uni0BCDuni0BB5_uni0BC1 
uni0B9A_uni0BC1uni0BB0_uni0BC1uni0B95_uni0BCDக ேநாயிuni0BB2_uni0BCD தமனி எதிuni0BAA_uni0BCDuni0BAA_uni0BC1 uni0B95_uni0BC1றிuni0BA4_uni0BCDuni0BA4_uni0BC1 மிuni0BA9_uni0BCD-ஒலி வைரuni0BB5_uni0BC1 ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசி ெசuni0BAF_uni0BCDய 
உuni0BB3_uni0BCDேளாuni0BAE_uni0BCD.   
 
ந+uni0B99_uni0BCDகuni0BB3_uni0BCD இuni0BA8_uni0BCDத ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BB2_uni0BCD பuni0B99_uni0BCDேகuni0BB1_uni0BCDக நாuni0B99_uni0BCDகuni0BB3_uni0BCD விuni0BB0_uni0BC1uni0BAE_uni0BCDuni0BAA_uni0BC1கிேறாuni0BAE_uni0BCD. இuni0BA8_uni0BCDத 
ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BB2_uni0BCD பuni0B99_uni0BCDேகuni0BB1_uni0BCDபதாuni0BB2_uni0BCD தuni0B99_uni0BCDகளuni0BA4_uni0BC1 ேநாயிuni0BA9_uni0BCD ஆuni0BAF_uni0BCDவறிuni0B95_uni0BCDைகேயா அuni0BB2_uni0BCDலuni0BA4_uni0BC1 
சிகிuni0B9A_uni0BCDைசேயா பாதிuni0B95_uni0BCDகuni0BAA_uni0BCDபடாuni0BA4_uni0BC1 எuni0BA9_uni0BCDபைதuni0BAF_uni0BC1uni0BAE_uni0BCD ெத/விuni0BA4_uni0BCDuni0BA4_uni0BC1uni0B95_uni0BCD ெகாuni0BB3_uni0BCDகிேறாuni0BAE_uni0BCD. 
இuni0BA8_uni0BCDத ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BA9_uni0BCD uni0BAE_uni0BC1uni0B9F_uni0BBFuni0BB5_uni0BC1கைள அuni0BB2_uni0BCDலuni0BA4_uni0BC1 கuni0BB0_uni0BC1uni0BA4_uni0BCDuni0BA4_uni0BC1கைள 
ெவளியிuni0B9F_uni0BC1uni0BAE_uni0BCD ேபாேதா அuni0BB2_uni0BCDலuni0BA4_uni0BC1 ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BA9_uni0BCD ேபாேதா தuni0B99_uni0BCDகளuni0BA4_uni0BC1 ெபயைரேயா 
அuni0BB2_uni0BCDலuni0BA4_uni0BC1 அைடயாளuni0B99_uni0BCDகைளேயா ெவளியிடமாuni0B9F_uni0BCDேடாuni0BAE_uni0BCD எuni0BA9_uni0BCDபைதuni0BAF_uni0BC1uni0BAE_uni0BCD 
ெத/விuni0BA4_uni0BCDuni0BA4_uni0BC1uni0B95_uni0BCD ெகாuni0BB3_uni0BCDகிேறாuni0BAE_uni0BCD. 
இuni0BA8_uni0BCDத ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BB2_uni0BCD பuni0B99_uni0BCDேகuni0BB1_uni0BCDபuni0BA4_uni0BC1 தuni0B99_uni0BCDகuni0BB3_uni0BC1ைடய விuni0BB0_uni0BC1uni0BAA_uni0BCDபuni0BA4_uni0BCDதிuni0BA9_uni0BCD 
ேப/uni0BB2_uni0BCD தாuni0BA9_uni0BCD இuni0BB0_uni0BC1uni0B95_uni0BCDகிறuni0BA4_uni0BC1. ேமuni0BB2_uni0BC1uni0BAE_uni0BCD ந+uni0B99_uni0BCDகuni0BB3_uni0BCD எuni0BA8_uni0BCDேநரuni0BAE_uni0BC1uni0BAE_uni0BCD இuni0BA8_uni0BCDத ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BB2_uni0BCD 
இuni0BB0_uni0BC1uni0BA8_uni0BCDuni0BA4_uni0BC1 பிuni0BA9_uni0BCDவாuni0B99_uni0BCDகலாuni0BAE_uni0BCD எuni0BA9_uni0BCDபைதuni0BAF_uni0BC1uni0BAE_uni0BCD ெத/விuni0BA4_uni0BCDuni0BA4_uni0BC1uni0B95_uni0BCDெகாuni0BB3_uni0BCDகிேறாuni0BAE_uni0BCD. 
இuni0BA8_uni0BCDத சிறuni0BAA_uni0BCDuni0BAA_uni0BC1uni0BAA_uni0BCD ப/ேசாதைனகளிuni0BA9_uni0BCD uni0BAE_uni0BC1uni0B9F_uni0BBFuni0BB5_uni0BC1கைள ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BA9_uni0BCD 
ேபாேதா அuni0BB2_uni0BCDலuni0BA4_uni0BC1 ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியிuni0BA9_uni0BCD uni0BAE_uni0BC1uni0B9F_uni0BBFவிuni0BA9_uni0BCD ேபாேதா தuni0B99_uni0BCDகuni0BB3_uni0BC1uni0B95_uni0BCDuni0B95_uni0BC1 அறிவிuni0BAA_uni0BCDேபாuni0BAE_uni0BCD 
எuni0BA9_uni0BCDபைதuni0BAF_uni0BC1uni0BAE_uni0BCD ெத/விuni0BA4_uni0BCDuni0BA4_uni0BC1uni0B95_uni0BCDேகாuni0BB3_uni0BCDகிேறாuni0BAE_uni0BCD.  
 
ஆராuni0BAF_uni0BCDuni0B9A_uni0BCDசியாள ைகெயாuni0BAA_uni0BCDபuni0BAE_uni0BCD                             பuni0B99_uni0BCDேகuni0BB1_uni0BCDபாள ைகெயாuni0BAA_uni0BCDபuni0BAE_uni0BCD 
ேததி: 
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ANTIPLAGIARISM CERTIFICATE 
 
 
 
 
 
 
 
 
 
 
 
 S.No Age Sex HT DM RHD
Smoking/
tobacco 
use 
Pulse 
rate 
 SBP DBP 
Pulse 
pressure
Height Weight BMI BSA SOB Angina Syncope Gidiness LVOT VTI BCAV
1 72 M 1 0 0 0 72 140 80 60 156 70 24.8 1.79 1 1 1 0 13 0
2 64 M 0 1 0 1 66 126 72 54 163 78 29.4 1.84 1 1 1 0 25 0
3 58 M 0 1 0 1 64 84 60 24 160 70 27.3 1.73 1 0 0 0 15 0
4 58 M 0 0 0 1 81 140 70 70 184 75 24.5 1.90 0 0 0 0 22 0
5 60 M 0 1 0 1 68 142 80 62 168 80 28.3 1.90 1 0 0 0 22 0
6 64 F 0 0 0 0 66 138 84 54 155 62 25.8 1.61 0 1 0 1 27 0
7 67 F 0 1 0 0 88 130 76 54 156 48 20.2 1.43 1 1 1 0 10 0
8 59 M 1 0 0 0 82 144 90 54 170 82 28.4 1.94 0 0 0 0 37 0
9 63 M 1 0 0 0 58 124 80 44 167 65 23.3 1.73 0 0 0 0 27 0
10 61 F 0 1 0 0 82 142 80 62 161 61 24.4 1.62 0 0 0 0 23 0
11 59 M 0 0 0 1 74 136 98 38 159 46 18.2 1.44 1 0 0 0 26 0
12 73 M 0 0 0 1 56 152 90 62 179 76 23.2 1.96 1 1 0 0 17 0
13 48 M 1 1 1 1 68 162 104 58 178 80 25.2 1.98 1 0 0 0 34 0
14 60 M 0 1 0 1 88 134 82 52 180 83 25.6 2.03 1 1 1 0 22 0
15 58 F 0 1 0 0 66 150 76 74 150 58 26.1 1.52 0 0 0 0 14 0
16 51 F 0 0 0 1 70 114 78 36 162 56 21.3 1.59 0 1 0 1 18 0
17 32 M 0 0 0 1 76 130 82 48 167 64 22.9 1.72 0 0 0 1 21 1
18 61 F 1 0 0 0 78 130 74 56 150 66 29.3 1.61 1 0 0 0 21 0
19 68 M 1 0 0 1 74 144 82 62 187 76 24.5 1.92 0 0 0 0 11 0
20 45 M 0 0 0 1 72 116 70 46 180 78 24.1 1.98 0 1 0 0 36 1
21 60 M 0 1 0 0 60 114 90 24 173 60 20.0 1.72 1 0 0 0 29 0
22 74 M 1 1 0 0 70 156 78 78 172 64 23.2 1.71 1 0 1 0 27 0
23 58 M 0 0 0 0 60 148 100 48 178 59 18.6 1.74 0 0 0 0 30 0
24 52 M 0 1 0 0 74 130 100 30 173 70 23.4 1.83 0 1 0 1 43 0
25 61 M 0 0 0 0 72 124 76 48 168 54 19.1 1.61 1 0 0 0 16 0
26 48 M 0 0 0 1 74 110 70 40 165 63 23.1 1.69 1 0 0 0 21 1
27 40 M 1 0 0 1 64 128 82 46 173 62 21.7 1.71 1 0 1 1 16 0
MASTER CHART
 S.No Age Sex HT DM RHD
Smoking/
tobacco 
use 
Pulse 
rate 
 SBP DBP 
Pulse 
pressure
Height Weight BMI BSA SOB Angina Syncope Gidiness LVOT VTI BCAV
28 56 M 0 0 0 0 76 120 82 38 170 66 22.8 1.77 0 0 0 0 21 0
29 48 M 1 0 0 1 80 140 80 60 163 63 23.7 1.68 0 1 1 1 25 0
30 56 F 0 0 0 0 90 132 84 48 154 55 23.2 1.52 1 1 0 1 13 0
31 61 F 1 0 0 0 70 162 94 68 154 50 21.1 1.46 0 0 0 0 25 0
32 51 F 0 0 1 0 66 100 72 28 156 50 20.5 1.47 0 0 0 0 24 0
33 53 M 0 1 0 0 58 96 64 32 159 52 20.6 1.52 1 1 0 1 15 0
34 54 F 0 1 0 0 82 100 72 28 167 72 25.8 1.81 0 0 1 0 20 0
35 39 M 0 0 0 1 81 136 78 58 182 83 25.1 2.04 1 1 0 1 25 1
36 58 M 1 1 0 1 68 144 92 52 167 75 26.9 1.84 1 0 0 0 17 0
37 60 M 0 0 0 0 68 118 68 50 173 80 26.7 1.94 0 0 0 0 18 0
38 81 M 1 0 0 0 78 164 90 74 176 65 22.0 1.77 1 0 1 1 14 0
39 56 M 1 0 0 0 60 130 90 40 172 74 25.0 1.87 0 0 0 0 23 0
40 80 M 1 0 0 0 61 152 80 72 164 60 23.7 1.61 1 0 0 0 14 0
41 66 F 0 1 0 0 78 148 70 78 167 78 30.5 1.81 0 0 0 0 15 0
42 55 M 0 1 0 1 69 118 70 48 179 80 25.0 1.99 0 0 0 1 28 0
43 58 M 1 0 0 0 76 130 82 48 172 70 23.7 1.83 1 0 0 0 20 0
44 52 F 1 1 0 0 74 142 90 52 154 48 20.2 1.43 1 0 0 0 17 0
45 70 F 1 1 0 0 82 134 80 54 168 70 24.8 1.79 1 0 0 1 24 0
46 56 M 0 0 0 0 68 124 82 42 176 84 27.1 2.01 1 0 0 0 38 0
47 68 M 1 1 0 0 68 162 90 72 172 73 25.6 1.83 1 0 1 1 28 0
 S.
No
LVOT 
dia 
AV peak 
velocity
AV VTI AV area 
Peak 
gradient 
Mean 
gradient 
IVS LVPW LVIDd RWT LVEF
Stroke 
Vol
SVI Mitral E Mitral A 
Mitral 
E/A DD
TDI E' E/E' MAPSE
LV Tei 
index
Zva
1 2.5 4.9 64 0.98 98 64 2.1 1.9 3.6 1.1 58 63 35 142 70 3 7.0 17 8.2 0.48 5.8
2 2.0 4.2 64 1.23 69 57 1.6 1.4 5.0 0.6 56 79 43 116 78 2 7.8 15 10.2 0.50 4.3
3 2.3 4.1 64 1.00 68 42 1.8 1.6 5.0 0.7 58 64 37 122 68 2 12.4 9.8 10.6 0.34 3.4
4 1.9 4.2 68 0.93 72 57 2.0 1.9 4.0 1.0 72 63 33 75 102 1 10.5 7.1 9.8 0.30 6.0
5 2.3 3.6 76 1.20 52 29 1.6 1.6 4.6 0.7 58 91 48 78 104 2 10.3 7.6 10.8 0.38 3.6
6 2.2 4.0 83 1.24 63 45 1.4 1.3 3.9 0.7 60 103 64 128 100 2 11.9 11 10.2 0.38 2.9
7 2.4 5.0 56 0.82 100 72 2.4 2.3 3.2 1.5 70 46 32 80 108 1 10.4 7.6 9.6 0.32 6.3
8 1.8 3.5 103 0.92 50 27 1.8 1.6 3.8 0.9 66 95 49 118 83 2 9.8 12 10.9 0.36 3.5
9 1.9 4.5 53 1.45 80 52 2.1 1.9 3.4 1.2 70 76 44 116 83 2 9.6 12 12.4 0.30 4.0
10 1.8 4.5 55 1.06 80 51 2.0 1.9 3.4 1.1 64 58 36 136 90 2 7.7 18 9.8 0.36 5.4
11 2.3 3.5 73 1.46 48 30 1.6 1.6 4.1 0.8 50 107 74 132 74 2 7.0 11 9.2 0.47 2.2
12 2.4 4.2 93 0.82 72 39 1.6 1.2 3.2 0.9 54 76 39 158 70 3 7.4 19 8.8 0.50 4.9
13 2.4 3.5 104 1.48 49 25 1.5 1.4 5.0 0.6 59 154 78 86 98 1 12.1 7.1 12.4 0.40 2.4
14 2.3 4.0 72 1.27 63 42 1.3 1.2 5.4 0.5 50 91 45 146 72 3 7.4 16 8.9 0.44 3.9
15 2.1 4.3 53 0.95 74 45 1.8 1.9 3.8 1.0 66 50 33 128 88 2 7.9 16 9.6 0.38 5.9
16 2.1 4.1 65 0.98 66 54 1.4 1.2 3.8 0.7 60 64 40 132 90 2 10.9 12 11.5 0.38 4.2
17 2.5 5.0 80 1.27 100 52 1.9 1.6 3.7 0.9 70 101 59 110 86 2 10.4 11 12.8 0.24 3.1
18 2.1 3.8 60 1.24 58 39 1.5 1.4 4.9 0.6 53 74 46 70 94 2 9.3 7.5 9.8 0.38 3.7
19 2.6 4.7 78 0.76 90 67 1.5 1.4 4.2 0.7 68 60 31 146 76 3 9.2 14 9.6 0.36 6.8
20 1.9 4.6 82 1.26 86 51 2.5 2.5 4.0 1.2 70 103 52 126 74 2 7.8 16 12.4 0.32 3.2
21 2.1 5.0 129 0.80 99 67 1.8 1.8 5.4 0.7 40 103 60 124 76 3 6.9 18 7.4 0.50 3.0
22 1.8 4.1 53 1.30 68 37 2.5 2.4 3.9 1.3 68 68 40 150 72 3 8.3 13 10.3 0.41 4.8
23 2.2 3.5 82 1.38 49 28 1.1 1.2 3.6 0.6 61 113 65 77 117 1 11.0 7 10.8 0.32 2.7
24 1.9 3.5 86 1.42 48 26 2.0 2.0 3.9 1.0 68 123 67 78 104 1 10.3 7.6 12.2 0.28 2.3
25 2.3 4.2 48 1.40 72 52 1.8 1.8 5.1 0.7 55 67 42 116 76 2 10.9 11 9.8 0.44 4.2
26 2.0 4.2 72 0.92 72 63 1.5 1.6 4.0 0.8 62 66 39 128 72 2 9.6 13 10.6 0.36 4.4
27 2.1 4.3 65 0.84 73 46 2.0 1.8 4.1 0.9 63 55 32 82 106 1 10.3 7.9 10 0.42 5.4
28 2.1 4.1 62 1.20 68 53 2.1 1.9 3.8 1.1 60 74 42 136 68 2 9.6 14 10.7 0.38 4.1
29 2.4 3.6 79 1.43 52 26 1.8 1.6 3.4 1.0 70 112 67 110 72 2 9.3 12 13 0.38 2.5
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30 2.6 4.2 48 1.43 70 48 1.4 1.5 5.6 0.5 54 68 45 128 72 2 12.5 10 10.2 0.47 4.0
31 2.0 3.7 53 1.48 54 26 2.0 1.9 4.0 1.0 63 79 54 110 68 2 11.7 9.4 10.5 0.32 3.5
32 1.9 4.6 52 1.30 84 56 1.6 1.6 3.8 0.8 69 68 46 124 70 2 11.5 11 12 0.36 3.4
33 2.4 4.2 57 1.23 72 60 1.7 1.5 5.1 0.6 56 70 46 90 108 1 4.8 19 10.5 0.44 3.4
34 2.3 4.2 67 1.24 72 53 1.5 1.4 4.7 0.6 60 83 46 82 100 1 11.4 7.2 10.2 0.28 3.3
35 2.2 4.0 67 1.43 64 32 1.7 1.7 3.8 0.9 58 96 47 78 106 1 10.0 7.8 9.9 0.39 3.6
36 2.6 3.8 65 1.36 58 34 1.8 1.4 5.9 0.5 48 88 48 134 90 2 9.3 14 9.6 0.46 3.7
37 2.4 4.2 63 1.32 72 54 1.7 1.6 4.7 0.7 62 83 43 118 72 2 9.4 13 10 0.32 4.0
38 2.4 4.4 70 0.93 76 42 1.4 1.4 4.6 0.6 50 65 37 144 78 3 6.9 19 7.5 0.49 5.6
39 2.2 3.9 61 1.45 60 42 1.8 1.7 3.4 1.0 62 88 47 86 110 2 11.6 7.4 10.8 0.32 3.7
40 2.2 4.6 59 0.87 86 64 1.6 1.5 3.4 0.9 60 52 32 138 92 2 7.9 17 8.4 0.48 6.8
41 2.3 4.5 62 1.02 82 53 2.3 2.1 4.6 1.0 61 63 35 118 86 2 9.3 13 9.7 0.42 5.7
42 2.1 4.2 71 1.35 70 40 1.6 1.5 4.2 0.7 59 95 48 74 104 1 10.1 7.3 11.4 0.28 3.3
43 2.2 3.9 81 0.92 62 43 1.5 1.3 4.2 0.7 58 75 41 146 68 3 7.3 20 10.6 0.42 4.2
44 2.6 3.6 68 1.36 52 32 1.3 1.2 4.5 0.6 54 92 64 147 77 3 7.9 19 9.5 0.40 2.7
45 2.1 3.7 63 1.32 56 44 1.6 1.5 5.3 0.6 56 83 46 134 88 2 11.6 12 10.6 0.36 3.9
46 1.9 4.6 106 1.02 86 50 1.8 1.6 4.0 0.9 58 108 54 124 84 2 10.7 12 10.1 0.41 3.2
47 1.9 4.1 67 1.21 68 36 1.8 1.8 4.0 0.9 66 81 44 128 102 2 8.3 15 9.4 0.44 4.5
